News

Direktlink :
Contents; Accesskey: 2 | Hauptnavigation; Accesskey: 3 | Servicenavigation; Accesskey: 4

News digest

28.03.2013 | newsdigest

March

Choice of mate influenced by odour-creating molecules +++ Roche invests €200 million in Penzberg +++ Berlin launch for ‘Ideen 2020’ exhibition +++ New Internet portal for European health research

28.02.2013 | newsdigest

Febuary

Commissioned study: More spray for GM crops +++ PGD: Federal Council approves regulation +++ Gene influences horse size +++ Qiagen and Lilly form diagnostics alliance +++ Heart tissue cultured from unfertilised egg cells

31.01.2013 | newsdigest

January

ERC funding for 21 top researchers in Germany +++ Strokes: Damaging immune cells trapped +++ Gene influences stress-related alcoholism +++ Penicillin fungus also reproduces through sex

31.12.2012 | newsdigest

December

Federal government increases 2013 research budget +++ ‘MitoFish’ provide insights for Alzheimer's research +++ Approval for Bremen monkey experiments +++ EU Parliament gives green light to uniform patent

30.11.2012 | newsdigest

November

Bayer to expand presence in Russia +++ New means of combating hepatitis C +++ Stem cell gene renders Hydra immortal +++ Geneticists defend prenatal screening for trisomy 21 +++ Sentinel cells newly formed in the immune system

31.10.2012 | newsdigest

October

Norovirus outbreak: Frozen strawberries triggered epidemic +++ Aicuris: Over €400 million for drug license +++ Researchers propose Europe-wide monitoring for transgenic plants +++ European Patent Office grants three patents for GM chimpanzees +++ Nobel laureates warn against EU research budget cuts

30.09.2012 | newsdigest

September

Switzerland: GMO moratorium under scrutiny +++ The Denisova people: little genetic diversity +++ Bayer seeks FDA approval for cancer drug +++ Biotech visionary Craig Venter acquires Febit patents +++ 4SC: Positive clinical trial data for epigenetic cancer drug

Science

In glass tubes standing metres high, the drug artemisinin is produced via the irradiation of a biotechnological intermediate. The pharmaceutical company Sanofi has constructed a new plant in Italy, which will be dedicated to the product. 02.05.2013 | Science Using synthetic biology for antimalarials

The highly effective malaria medicine artemisinin is now being biotechnologically produced for the first time on an industrial scale. It is a prime example of the potential of synthetic biology.

more
 
 
Complete list

Business

German biotech companies saw a significant increase in turnover in 2012, although R&D spending dipped. 19.04.2013 | Business Record turnover, more employees in the biotechnology sector

More turnover, more employees, more companies – the recent 2013 company survey by biotechnologie.de paints a picture of a biotechnology sector on a growth path.

more
 
 
Complete list

Funding

Antibiotics (visible here as a halo around the white pads) are the most important weapons in the fight against pathogens (white stripes). A decreasing number of such agents are effective against multi-resistant bacteria. 21.02.2013 | Funding The antibiotic offensive

Ever more bacteria are developing resistance to antibiotics, and the supply of new drugs against dangerous microbes is failing to keep pace. A new EU research consortium is hoping to change this state of affairs.

more
 
 
Complete list

Politics

The 2013 Leibniz Prize winners with Federal Minister Johanna Wanka (front, fourth from right) and DFG President Peter Strohschneider (third from right) and minister Sabine Kunst (Brandenburg, second on right) 05.04.2013 | Politics 2013 Leibniz Prize

Eleven top German researchers have been awarded the 2013 Leibniz Prize in a ceremony in Berlin. Five of the winners work in fields related to the life sciences.

more
 
 
Complete list